Skip to content

Sofosbuvir Impurity 33

Sofosbuvir Impurity 33

Product Description
CAT No.
ALN-S010056
CAS No.
1910099-11-4
Mol. F.
C24H22N2O8
Mol. Wt.
466.5
Stock
Please Inquire
Chemical Name : ((2R,3R,4S,5R)-3-(Benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-4-methyltetrahydrofuran-2-yl)methyl benzoate
Smiles : C[C@]1(O)[C@H](OC(C2=CC=CC=C2)=O)[C@@H](COC(C3=CC=CC=C3)=O)O[C@H]1N4C(NC(C=C4)=O)=O
Inchi : InChI=1S/C24H23N3O7/c1-24(31)19(34-21(29)16-10-6-3-7-11-16)17(14-32-20(28)15-8-4-2-5-9-15)33-22(24)27-13-12-18(25)26-23(27)30/h2-13,17,19,22,31H,14H2,1H3,(H2,25,26,30)/t17-,19-,22+,24+/m1/s1

Method development and validation for the simultaneous estimation of sofosbuvir and velpatasvir in bulk and tablet dosage forms by RP-HPLC

By Suma, M. S. M.; Gowthami, M.; Latha, P. V. Madhavi; Devi, P. UmanFrom Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9037-9043.

Development and validation of RP-HPLC method for the estimation of Sofosbuvir and Ledipasvir in combined dosage form

By Prabhaker, Naik Desai Prabhat; Pankaj, Kapupara – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2021), 12(1), 523-529.

Eco-friendly HPTLC method for simultaneous analysis of sofosbuvir and ledipasvir in biological and pharmaceutical samples: Stability indicating study

By El-Yazbi, Amira F.; Elashkar, Nourhan E.; Abdel-Hay, Karim M.; Talaat, Wael; Ahmed, Hytham M. – From Microchemical Journal (2020), 154, 104584.

Request For Quotation